What is the primary objective of launching India's first National Biofoundry Network under the BioE3 policy i… - RRB Nsg. Superintendent-2026 (Shift -1st)

RRB Nsg. Superintendent-2026 (Shift -1st)

Microbiology

Medium

Appeared in: RRB Nsg. Superintendent-2026 (Shift -1st)

Explanation

The term 'foundry' itself refers to a factory for production, so a 'biofoundry' is a factory for biological production or biomanufacturing.
The BioE3 policy's full name is Biotechnology for Economy, Environment, and Employment, which points towards industrial and economic development through biotechnology.
The primary goal is to create a robust infrastructure for scaling up biotechnological innovations into industrial products, thereby boosting the bioeconomy.
This initiative aims to make India a global hub for biomanufacturing and bio-innovation, reducing reliance on traditional, less sustainable manufacturing processes.

Option B: Skill training is a supporting activity, not the primary objective of establishing a manufacturing facility. It is a means to an end, not the end goal itself.
Option C: Gene editing is a specific molecular tool used in biotechnology. A biofoundry's purpose is to use such tools for large-scale production, not just to perform the editing.
Option D: The BioE3 policy is focused on the bioeconomy and industrial applications of biotechnology, not on ecological research or wildlife conservation.

Visual 1: Infographic - A flowchart showing how a biofoundry takes a lab-scale biological concept, optimizes it using automation and AI, and scales it up for industrial biomanufacturing of products like biofuels, bioplastics, and pharmaceuticals.
Visual 2: Diagram - A simple diagram illustrating the pillars of the BioE3 policy: Economy (new products, jobs), Environment (sustainability, reduced pollution), and Employment (skilled workforce).

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Objectives of India's BioE3 policy and the National Biofoundry Network as background academic context rather than a clinical decision trigger.
This topic is relevant for understanding the national policy context that drives innovation in pharmaceuticals, vaccines, and medical devices, which directly impacts healthcare.
The growth of biomanufacturing can lead to the domestic production of affordable and advanced medical products, improving access for patients.
A focus on biomanufacturing can lead to the development of new diagnostic tools, therapies, and vaccines, which nurses will eventually administer and manage.

How to Approach the Question

First, analyze the key terms in the question: 'Biofoundry' and 'BioE3 policy'.
Break down the term 'Biofoundry'. 'Bio' relates to biology, and 'foundry' is a place for manufacturing. This strongly suggests 'Biomanufacturing'.
Consider the full name of the BioE3 policy: Biotechnology for Economy, Environment, and Employment. The 'Economy' and 'Employment' aspects point towards industrial activity and production.
Evaluate the options in this context. 'Skill training' and 'Gene editing' are components or tools, not the overarching objective. 'Wildlife study' is an unrelated field.
Conclude that 'Biomanufacturing' is the only option that aligns with the industrial and economic goals implied by both 'biofoundry' and the 'BioE3' policy.

Concept Tested & Keywords

Concept Tested: Objectives of India's BioE3 policy and the National Biofoundry Network
Stem keywords: National Biofoundry Network, BioE3 policy, primary objective
Lead-in keywords: What is

QVSKAliJiZpRZo9WeJ3xrC